ReSearch Pharma Files for $100 Million IPO


ReSearch Pharmaceutical Services Inc., a Fort Washington, Penn.-based provider of clinical development services to the biopharmaceutical industry, has filed for a $100 million IPO. It plans to trade on the Nasdaq, with Jefferies & Co. serving as lead underwriter.

The company reports around $224 million in 2009 revenue, up from $175 million in 2008. Its 2009 net income was $2.6 million.

ReSearch Pharma shareholders include Cartesian Capital, The Argentum Group and First Analysis. www.rpsweb.com

Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now

Sign up to our Newsletter

Receive updates from our PE HUB Wire and Top Stories of the Week newsletters:

We will not send you spam, and we don't share your email address with 3rd parties.